Skip to main content
Erschienen in:

28.11.2024 | Original Article

Prognostic impact of preoperative osteosarcopenia on esophageal cancer surgery outcomes: a retrospective analysis

verfasst von: Yuki Hirase, Ken Sasaki, Yusuke Tsuruda, Masataka Shimonosono, Yasuto Uchikado, Daisuke Matsushita, Takaaki Arigami, Nobuhiro Tada, Kenji Baba, Yota Kawasaki, Takao Ohtsuka

Erschienen in: Esophagus | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Abstract

Background

Osteosarcopenia, recognized as a consequence of aging, has garnered attention as a prognostic marker in recent years; however, its clinical significance in esophageal cancer remains uncertain. This study aimed to investigate the impact of osteosarcopenia on esophageal cancer surgery outcomes.

Methods

This retrospective study included patients with advanced esophageal cancer who underwent surgical resection between 2018 and 2021. Skeletal muscle index at the L3 vertebral level and bone density at the Th11 vertebral level were measured on preoperative computed tomography scans. Based on the findings, we divided patients into sarcopenia, osteopenia, and osteosarcopenia groups, and analyzed the relationship between osteosarcopenia and clinicopathological factors, including prognosis.

Results

Of the 124 patients included, 59 (48%) were diagnosed with osteosarcopenia. Among all, 46 (37%) patients experienced postoperative recurrence, and a significant correlation was observed between osteosarcopenia and recurrence (p < 0.05). Overall survival and relapse-free survival were significantly shorter in the osteosarcopenia group than in the non-osteosarcopenia group (p < 0.05 for both). In a subgroup analysis, overall survival and relapse-free survival were significantly shorter in the osteosarcopenia group than in the non-osteosarcopenia group, or in the sarcopenia and osteopenia alone groups (all p < 0.05).

Conclusions

The presence of preoperative osteosarcopenia was found to affect the prognosis following esophageal cancer surgery.
Literatur
1.
Zurück zum Zitat Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.CrossRefPubMed Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.CrossRefPubMed
2.
Zurück zum Zitat Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2023;21:393–422.CrossRef Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2023;21:393–422.CrossRef
3.
Zurück zum Zitat Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Prim. 2017;3:17048.CrossRefPubMed Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Prim. 2017;3:17048.CrossRefPubMed
5.
Zurück zum Zitat Kanemura T, Takeoka T, Sugase T, et al. Significance of comprehensive analysis of preoperative sarcopenia based on muscle mass, muscle strength, and physical function for the prognosis of patients with esophageal cancer. Ann Surg Oncol. 2024;31:818–26.CrossRefPubMed Kanemura T, Takeoka T, Sugase T, et al. Significance of comprehensive analysis of preoperative sarcopenia based on muscle mass, muscle strength, and physical function for the prognosis of patients with esophageal cancer. Ann Surg Oncol. 2024;31:818–26.CrossRefPubMed
6.
Zurück zum Zitat Takahashi K, Nishikawa K, Furukawa K, et al. Prognostic significance of preoperative osteopenia in patients undergoing esophagectomy for esophageal cancer. World J Surg. 2021;45:3119–28.CrossRefPubMed Takahashi K, Nishikawa K, Furukawa K, et al. Prognostic significance of preoperative osteopenia in patients undergoing esophagectomy for esophageal cancer. World J Surg. 2021;45:3119–28.CrossRefPubMed
7.
Zurück zum Zitat Watanabe J, Saitsu A, Miki A, et al. Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis. Arch Osteoporos. 2022;17:33.CrossRefPubMedPubMedCentral Watanabe J, Saitsu A, Miki A, et al. Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis. Arch Osteoporos. 2022;17:33.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Abe T, Nakata K, Nakamura S, et al. Prognostic impact of preoperative osteosarcopenia for patients with pancreatic ductal adenocarcinoma after curative resection. Ann Surg Oncol. 2023;30:6673–9.CrossRefPubMed Abe T, Nakata K, Nakamura S, et al. Prognostic impact of preoperative osteosarcopenia for patients with pancreatic ductal adenocarcinoma after curative resection. Ann Surg Oncol. 2023;30:6673–9.CrossRefPubMed
9.
Zurück zum Zitat Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12:36–42.CrossRefPubMed Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12:36–42.CrossRefPubMed
10.
Zurück zum Zitat Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20:343–72.CrossRefPubMedPubMedCentral Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20:343–72.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088–98.CrossRefPubMed Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088–98.CrossRefPubMed
12.
Zurück zum Zitat Gomez-Perez SL, Haus JM, Sheean P, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for clinicians using national institutes of health imageJ. JPEN J Parenter Enter Nutr. 2016;40:308–18.CrossRef Gomez-Perez SL, Haus JM, Sheean P, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for clinicians using national institutes of health imageJ. JPEN J Parenter Enter Nutr. 2016;40:308–18.CrossRef
13.
Zurück zum Zitat Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr. 2010;29:154–9.CrossRefPubMed Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr. 2010;29:154–9.CrossRefPubMed
14.
Zurück zum Zitat Miyachi Y, Kaido T, Yao S, et al. Bone mineral density as a risk factor for patients undergoing surgery for hepatocellular carcinoma. World J Surg. 2019;43:920–8.CrossRefPubMed Miyachi Y, Kaido T, Yao S, et al. Bone mineral density as a risk factor for patients undergoing surgery for hepatocellular carcinoma. World J Surg. 2019;43:920–8.CrossRefPubMed
16.
Zurück zum Zitat Bossi P, Delrio P, Mascheroni A, et al. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13:1980.CrossRefPubMedPubMedCentral Bossi P, Delrio P, Mascheroni A, et al. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13:1980.CrossRefPubMedPubMedCentral
17.
18.
Zurück zum Zitat Bruunsgaard H, Pedersen BK. Special feature for the olympics: effects of exercise on the immune system: effects of exercise on the immune system in the elderly population. Immunol Cell Biol. 2000;78:523–31.CrossRefPubMed Bruunsgaard H, Pedersen BK. Special feature for the olympics: effects of exercise on the immune system: effects of exercise on the immune system in the elderly population. Immunol Cell Biol. 2000;78:523–31.CrossRefPubMed
19.
Zurück zum Zitat Furukawa K, Haruki K, Taniai T, et al. Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases. Ann Gastroenterol Surg. 2021;5:390–8.CrossRefPubMedPubMedCentral Furukawa K, Haruki K, Taniai T, et al. Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases. Ann Gastroenterol Surg. 2021;5:390–8.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Park JS, Colby M, Seyfi D, et al. Sarcopenia impacts perioperative and survival outcomes after esophagectomy for cancer a multicenter study. J Gastrointest Surg. 2024;28:805–12.CrossRefPubMed Park JS, Colby M, Seyfi D, et al. Sarcopenia impacts perioperative and survival outcomes after esophagectomy for cancer a multicenter study. J Gastrointest Surg. 2024;28:805–12.CrossRefPubMed
21.
Zurück zum Zitat Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.CrossRefPubMed Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.CrossRefPubMed
22.
Zurück zum Zitat Jones DH, Nakashima T, Sanchez OH, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 2006;440:692–6.CrossRefPubMed Jones DH, Nakashima T, Sanchez OH, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 2006;440:692–6.CrossRefPubMed
23.
Zurück zum Zitat Tustumi F, Takeda FR, Viyuela MS, et al. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. J Surg Oncol. 2020;121:784–94.CrossRefPubMed Tustumi F, Takeda FR, Viyuela MS, et al. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. J Surg Oncol. 2020;121:784–94.CrossRefPubMed
24.
Zurück zum Zitat Miyata H, Yamasaki M, Kurokawa Y, et al. Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med. 2011;2:879–85.CrossRefPubMedPubMedCentral Miyata H, Yamasaki M, Kurokawa Y, et al. Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med. 2011;2:879–85.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Zhang Y, Han N, Zeng X, et al. Impact of platelets to lymphocytes ratio and lymphocytes during radical concurrent radiotherapy and chemotherapy on patients with nonmetastatic esophageal squamous cell carcinoma. J Oncol. 2022;2022:3412349.PubMedPubMedCentral Zhang Y, Han N, Zeng X, et al. Impact of platelets to lymphocytes ratio and lymphocytes during radical concurrent radiotherapy and chemotherapy on patients with nonmetastatic esophageal squamous cell carcinoma. J Oncol. 2022;2022:3412349.PubMedPubMedCentral
27.
Zurück zum Zitat Wu J, Chi H, Kok S, et al. Multimodal prerehabilitation for elderly patients with sarcopenia in colorectal surgery. Ann Coloproctol. 2024;40:3–12.CrossRefPubMed Wu J, Chi H, Kok S, et al. Multimodal prerehabilitation for elderly patients with sarcopenia in colorectal surgery. Ann Coloproctol. 2024;40:3–12.CrossRefPubMed
Metadaten
Titel
Prognostic impact of preoperative osteosarcopenia on esophageal cancer surgery outcomes: a retrospective analysis
verfasst von
Yuki Hirase
Ken Sasaki
Yusuke Tsuruda
Masataka Shimonosono
Yasuto Uchikado
Daisuke Matsushita
Takaaki Arigami
Nobuhiro Tada
Kenji Baba
Yota Kawasaki
Takao Ohtsuka
Publikationsdatum
28.11.2024
Verlag
Springer Nature Singapore
Erschienen in
Esophagus / Ausgabe 1/2025
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-024-01101-8

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.